VBI Vaccines Inc.
160 Second Street, Floor 3
Cambridge, MA 02142
(617) 830-3031
September 2, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549
Attention: Tim Buchmiller
Re: | VBI Vaccines Inc. | |
Registration Statement on Form S-3, originally filed on August 26, 2022 | ||
File No. 333-267109 (the “Registration Statement”) |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, VBI Vaccines Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 5:00 p.m., Eastern Time, on September 6, 2022, or as soon thereafter as practicable.
Should any member of the staff of the U.S. Securities and Exchange Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Jayun Koo, Esq. at (212) 835-4823.
Very truly yours, | ||
VBI Vaccines Inc. | ||
By: | /s/ Christopher McNulty | |
Christopher McNulty | ||
Chief Financial Officer and | ||
Head of Business Development |